142 related articles for article (PubMed ID: 38888291)
1. Ocular Drug-Metabolizing Enzymes: Focus on Esterases.
Hammid A; Honkakoski P
Drug Metab Rev; 2024 Jun; ():1-23. PubMed ID: 38888291
[No Abstract] [Full Text] [Related]
2. Activity and Expression of Carboxylesterases and Arylacetamide Deacetylase in Human Ocular Tissues.
Hammid A; Fallon JK; Lassila T; Vieiro P; Balla A; Gonzalez F; Urtti A; Smith PC; Tolonen A; Honkakoski P
Drug Metab Dispos; 2022 Dec; 50(12):1483-1492. PubMed ID: 36195336
[TBL] [Abstract][Full Text] [Related]
3. Role of metabolism in ocular drug delivery.
Duvvuri S; Majumdar S; Mitra AK
Curr Drug Metab; 2004 Dec; 5(6):507-15. PubMed ID: 15578944
[TBL] [Abstract][Full Text] [Related]
4. Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistance.
Larsen EM; Johnson RJ
Drug Dev Res; 2019 Feb; 80(1):33-47. PubMed ID: 30302779
[TBL] [Abstract][Full Text] [Related]
5. Esterase activity in porcine and albino rabbit ocular tissues.
Heikkinen EM; Del Amo EM; Ranta VP; Urtti A; Vellonen KS; Ruponen M
Eur J Pharm Sci; 2018 Oct; 123():106-110. PubMed ID: 30030098
[TBL] [Abstract][Full Text] [Related]
6. Studies on a novel series of acyl ester prodrugs of prostaglandin F2 alpha.
Cheng-Bennett A; Chan MF; Chen G; Gac T; Garst ME; Gluchowski C; Kaplan LJ; Protzman CE; Roof MB; Sachs G
Br J Ophthalmol; 1994 Jul; 78(7):560-7. PubMed ID: 7918269
[TBL] [Abstract][Full Text] [Related]
7. Influence of chain length on the in vitro hydrolysis of model ester prodrugs by ocular esterases.
Chang SC; Lee VH
Curr Eye Res; 1982-1983; 2(10):651-6. PubMed ID: 7186434
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450, drug metabolizing enzymes and arachidonic acid metabolism in bovine ocular tissues.
Schwartzman ML; Masferrer J; Dunn MW; McGiff JC; Abraham NG
Curr Eye Res; 1987 Apr; 6(4):623-30. PubMed ID: 3107908
[TBL] [Abstract][Full Text] [Related]
9. Enzymes involved in the bioconversion of ester-based prodrugs.
Liederer BM; Borchardt RT
J Pharm Sci; 2006 Jun; 95(6):1177-95. PubMed ID: 16639719
[TBL] [Abstract][Full Text] [Related]
10. Interspecies differences in stability kinetics and plasma esterases involved in hydrolytic activation of curcumin diethyl disuccinate, a prodrug of curcumin.
Ratnatilaka Na Bhuket P; Jithavech P; Ongpipattanakul B; Rojsitthisak P
RSC Adv; 2019 Jan; 9(8):4626-4634. PubMed ID: 35520191
[TBL] [Abstract][Full Text] [Related]
11. Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues.
Hammid A; Fallon JK; Lassila T; Salluce G; Smith PC; Tolonen A; Sauer A; Urtti A; Honkakoski P
Mol Pharm; 2021 Mar; 18(3):1305-1316. PubMed ID: 33595329
[TBL] [Abstract][Full Text] [Related]
12. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
[TBL] [Abstract][Full Text] [Related]
13. Role of membrane transporters and metabolizing enzymes in ocular drug delivery.
Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
Curr Drug Metab; 2014; 15(7):680-93. PubMed ID: 25255873
[TBL] [Abstract][Full Text] [Related]
14. Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma.
Ahmed S; Imai T; Yoshigae Y; Otagiri M
Life Sci; 1997; 61(19):1879-87. PubMed ID: 9364192
[TBL] [Abstract][Full Text] [Related]
15. [Human drug metabolizing enzymes III. Epoxide hydrolases, esterases, and amidases].
Hazai E; Róna K; Vereczkey L
Acta Pharm Hung; 1999 Sep; 69(4):208-12. PubMed ID: 10544521
[TBL] [Abstract][Full Text] [Related]
16. Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes.
Argikar UA; Dumouchel JL; Dunne CE; Bushee AJ
Drug Metab Rev; 2017 Aug; 49(3):372-394. PubMed ID: 28438049
[TBL] [Abstract][Full Text] [Related]
17. Hydrolytic biotransformation of the bumetanide ester prodrug DIMAEB to bumetanide by esterases in neonatal human and rat serum and neonatal rat brain-A new treatment strategy for neonatal seizures?
Theilmann W; Brandt C; Bohnhorst B; Winstroth AM; Das AM; Gramer M; Kipper A; Kalesse M; Löscher W
Epilepsia; 2021 Jan; 62(1):269-278. PubMed ID: 33140458
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of human esterases.
Fukami T; Yokoi T
Drug Metab Pharmacokinet; 2012; 27(5):466-77. PubMed ID: 22813719
[TBL] [Abstract][Full Text] [Related]
19. In-vitro hydrolysis, permeability, and ocular uptake of prodrugs of N-[4-(benzoylamino)phenylsulfonyl]glycine, a novel aldose reductase inhibitor.
Sunkara G; Deruiter J; Clark CR; Kompella UB
J Pharm Pharmacol; 2000 Sep; 52(9):1113-22. PubMed ID: 11045892
[TBL] [Abstract][Full Text] [Related]
20. Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivo.
Lorenzi PL; Landowski CP; Song X; Borysko KZ; Breitenbach JM; Kim JS; Hilfinger JM; Townsend LB; Drach JC; Amidon GL
J Pharmacol Exp Ther; 2005 Aug; 314(2):883-90. PubMed ID: 15901797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
